Agilent Technologies Inc (A): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Agilent Technologies ( A) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.5%. By the end of trading, Agilent Technologies rose $1.13 (2.0%) to $56.37 on average volume. Throughout the day, 3,108,313 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 2,752,200 shares. The stock ranged in a price between $55.81-$57.29 after having opened the day at $55.96 as compared to the previous trading day's close of $55.24. Other companies within the Health Services industry that increased today were: Stereotaxis ( STXS), up 11.0%, BioScrip ( BIOS), up 8.9%, Mazor Robotics ( MZOR), up 6.6% and Navidea Biopharmaceuticals ( NAVB), up 5.8%.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $18.2 billion and is part of the health care sector. The company has a P/E ratio of 19.1, above the S&P 500 P/E ratio of 17.7. Shares are up 34.9% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Rockwell Medical ( RMTI), down 19.8%, CombiMatrix Corporation ( CBMX), down 19.3%, BG Medicine ( BGMD), down 9.2% and USMD Holdings ( USMD), down 7.9% , were all laggards within the health services industry with Intuitive Surgical ( ISRG) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

More from Markets

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Trump Takes Aim at Auto Imports; Markets End Mixed -- ICYMI

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

Video: What Oprah's Content Partnership With Apple Means for the Rest of Tech

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

REPLAY: Jim Cramer on the Markets, Oil, Starbucks, Tesla, Okta and Red Hat

Flashback Friday: The Market Movers

Flashback Friday: The Market Movers